Discover 1,672 paid clinical trials in Sandy Springs, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,672
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
for
Breast Cancer, Ovarian Cancer
Location: Atlanta GA
Sponsor: Emory University
Sex: Female
Age: 25+
Code: NCT06760507
Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Atlanta GA, Charlotte NC, Matthews NC, Huntersville NC,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase 3, Recruiting
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Atlanta GA, Durham NC, Houston TX, Boston MA, Orange CA
Sponsor: Philogen S.p.A.
Sex: All
Age: 18+
Code: NCT07228442
Phase 2, Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Atlanta GA, Nashville TN, Chapel Hill NC, Columbus OH,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07441694
Phase 1, Recruiting
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Atlanta GA, Louisville KY, Orange City FL, Clermont FL,
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
for
Adult Acute Myeloid Leukemia
Location: Atlanta GA, Cincinnati OH, Tampa FL, Cleveland OH,
Sponsor: Priothera SAS
Sex: All
Age: 18 - 70+
Code: NCT05429632
Phase 3, Recruiting
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
for
Multiple Myeloma, Smoldering Multiple Myeloma,
Location: Atlanta GA, Denver CO
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06768489
Phase 1, Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Prostatic Neoplasms, Castration-Resistant
Location: Atlanta GA, Knoxville TN, Louisville KY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07225946
Phase 3, Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Athens GA, Germantown TN, Roanoke VA, Durham NC,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase 3, Recruiting
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
for
Breast Neoplasms
Location: Atlanta GA
Sponsor: Georgia Center for Oncology Research & Education
Sex: Female
Age: 18+
Code: NCT00415285
Phase 2, Recruiting
Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
Location: Atlanta GA, Indianapolis IN, Boston MA, Newark NJ,
Sponsor: Theragenics Corporation
Sex: All
Age: 50+
Code: NCT00100087
Phase 1, Phase 2, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)